Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MRNA | Moderna, Inc.

IndexNDX, S&P 500 P/E37.08 EPS (ttm)2.70 Insider Own2.40% Shs Outstand381.00M Perf Week-12.50%
Market Cap37.57B Forward P/E- EPS next Y-5.17 Insider Trans-13.76% Shs Float343.79M Perf Month-13.16%
Income1.21B PEG- EPS next Q-1.58 Inst Own65.90% Short Float / Ratio5.25% / 4.70 Perf Quarter-15.39%
Sales10.65B P/S3.53 EPS this Y-29.00% Inst Trans0.91% Short Interest18.05M Perf Half Y-32.90%
Book/sh44.49 P/B2.25 EPS next Y-47.80% ROA4.90% Target Price181.35 Perf Year-20.27%
Cash/sh22.58 P/C4.44 EPS next 5Y- ROE6.60% 52W Range95.02 - 217.25 Perf YTD-44.18%
Dividend- P/FCF- EPS past 5Y92.10% ROI40.60% 52W High-53.85% Beta1.65
Dividend %- Quick Ratio3.20 Sales past 5Y147.90% Gross Margin57.40% 52W Low5.52% ATR4.70
Employees3900 Current Ratio3.40 Sales Q/Q-92.80% Oper. Margin4.80% RSI (14)38.66 Volatility5.15% 4.06%
OptionableYes Debt/Eq0.06 EPS Q/Q-169.10% Profit Margin11.30% Rel Volume0.45 Prev Close100.23
ShortableYes LT Debt/Eq0.05 EarningsAug 03 BMO Payout0.00% Avg Volume3.84M Price100.26
Recom2.50 SMA20-8.51% SMA50-10.07% SMA200-29.67% Volume1,462,551 Change0.03%
Date Action Analyst Rating Change Price Target Change
Aug-04-23Downgrade TD Cowen Outperform → Market Perform $145 → $125
Aug-03-23Downgrade Deutsche Bank Buy → Hold $125
Jul-24-23Initiated William Blair Mkt Perform $136.28
Jul-14-23Initiated HSBC Securities Reduce $97
Jun-26-23Upgrade UBS Neutral → Buy $221 → $191
Apr-26-23Initiated Guggenheim Neutral
Mar-13-23Upgrade TD Cowen Market Perform → Outperform $150 → $180
Mar-02-23Initiated RBC Capital Mkts Outperform $200
Feb-24-23Downgrade SVB Securities Market Perform → Underperform $111 → $93
Dec-19-22Upgrade Jefferies Hold → Buy $170 → $275
Today 12:00PM
11:26AM
08:45AM
Sep-21-23 01:34PM
01:34PM
10:57AM Loading…
10:57AM
10:43AM
08:26AM
07:30AM
05:30AM
Sep-20-23 11:27AM
07:45AM
05:30AM
Sep-19-23 12:29PM
11:31AM
11:01AM Loading…
11:01AM
10:49AM
10:25AM
07:30AM
03:28AM
Sep-18-23 05:23PM
04:45PM
04:43PM
04:01PM
02:27PM
12:45PM
07:22AM
05:15AM
Sep-17-23 02:26PM
05:30AM
05:50PM Loading…
Sep-15-23 05:50PM
02:51PM
10:30AM
09:35AM
09:33AM
06:47AM
06:19AM
05:30AM
Sep-14-23 04:17PM
04:14PM
04:00PM
01:18PM
11:25AM
10:18AM
10:15AM
10:12AM
10:10AM
09:37AM
05:31AM
05:00AM
12:30AM
Sep-13-23 04:42PM
04:33PM
04:07PM
04:00PM
02:42PM
02:31PM
01:50PM
01:19PM
01:18PM
12:54PM
12:52PM
12:30PM
12:19PM
12:15PM
12:15PM
11:31AM
11:29AM
10:14AM
09:30AM
09:18AM
08:12AM
06:53AM
06:37AM
06:30AM
06:30AM
06:30AM
06:30AM
04:51AM
Sep-12-23 06:20PM
05:37PM
05:22PM
01:22PM
11:56AM
10:26AM
09:33AM
09:00AM
06:00AM
01:01AM
Sep-11-23 07:59PM
05:58PM
05:19PM
05:17PM
04:51PM
04:03PM
03:48PM
03:04PM
02:12PM
02:07PM
01:53PM
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoge StephenPresidentSep 15Sale112.9915,0001,694,8501,574,187Sep 18 04:06 PM
AFEYAN NOUBARDirectorSep 13Sale109.7015,0001,645,5222,221,931Sep 15 07:00 PM
Klinger Shannon ThymeChief Legal OfficerSep 08Sale107.2255759,7227,215Sep 11 04:02 PM
AFEYAN NOUBARDirectorSep 06Sale107.6115,0001,614,0941,982,209Sep 08 07:01 PM
Garay ArpaChief Commercial OfficerSep 06Sale108.4057462,2193,113Sep 07 04:46 PM
Hoge StephenPresidentSep 05Sale111.4432035,6601,589,187Sep 06 04:08 PM
Klinger Shannon ThymeChief Legal OfficerSep 05Sale111.4411512,8156,634Sep 06 04:17 PM
AFEYAN NOUBARDirectorAug 30Sale115.4615,0001,731,9511,997,209Sep 01 07:00 PM
Hoge StephenPresidentAug 29Sale115.011,135130,5421,588,855Aug 30 04:07 PM
AFEYAN NOUBARDirectorAug 23Sale115.5115,0001,732,6132,012,209Aug 25 07:00 PM
Hoge StephenPresidentAug 17Sale100.0015,0001,500,0001,587,579Aug 18 05:16 PM
AFEYAN NOUBARDirectorAug 16Sale97.5610,000975,6142,027,209Aug 18 07:01 PM
Hoge StephenPresidentAug 10Sale102.5324725,3251,602,579Aug 11 04:18 PM
AFEYAN NOUBARDirectorAug 02Sale110.9915,0001,664,8762,037,209Aug 04 07:00 PM
AFEYAN NOUBARDirectorJul 26Sale120.4215,0001,806,2292,052,209Jul 28 07:05 PM
AFEYAN NOUBARDirectorJul 19Sale125.4815,0001,882,1522,067,209Jul 21 07:00 PM
Hoge StephenPresidentJul 17Sale120.6015,0001,809,0001,602,303Jul 18 04:35 PM
AFEYAN NOUBARDirectorJul 12Sale125.8115,0001,887,0812,082,209Jul 14 07:01 PM
AFEYAN NOUBARDirectorJul 05Sale124.7315,0001,870,9332,097,209Jul 07 07:00 PM
Bancel StephaneChief Executive OfficerJun 28Option Exercise0.9927,15526,8835,439,101Jun 30 04:51 PM
Bancel StephaneChief Executive OfficerJun 28Sale121.6327,1553,302,9075,411,946Jun 30 04:51 PM
AFEYAN NOUBARDirectorJun 28Sale121.5415,0001,823,1602,112,209Jun 30 07:02 PM
Bancel StephaneChief Executive OfficerJun 22Option Exercise0.9940,00039,6005,451,946Jun 23 04:03 PM
Bancel StephaneChief Executive OfficerJun 22Sale119.4140,0004,776,4275,411,946Jun 23 04:03 PM
Bancel StephaneChief Executive OfficerJun 21Option Exercise0.9940,00039,6005,451,946Jun 23 04:03 PM
Bancel StephaneChief Executive OfficerJun 21Sale121.9840,0004,879,2875,411,946Jun 23 04:03 PM
AFEYAN NOUBARDirectorJun 21Sale121.9515,0001,829,2272,127,209Jun 23 07:01 PM
Bancel StephaneChief Executive OfficerJun 15Option Exercise0.9940,00039,6005,451,946Jun 16 04:15 PM
Bancel StephaneChief Executive OfficerJun 15Sale128.4140,0005,136,3885,411,946Jun 16 04:15 PM
Hoge StephenPresidentJun 15Sale125.9315,0001,888,9501,617,303Jun 16 04:10 PM
Bancel StephaneChief Executive OfficerJun 14Option Exercise0.9940,00039,6005,451,946Jun 16 04:15 PM
Bancel StephaneChief Executive OfficerJun 14Sale126.1440,0005,045,4865,411,946Jun 16 04:15 PM
AFEYAN NOUBARDirectorJun 14Sale126.1815,0001,892,6272,142,209Jun 16 07:00 PM
Bancel StephaneChief Executive OfficerJun 08Option Exercise0.9940,00039,6005,451,946Jun 09 04:14 PM
Bancel StephaneChief Executive OfficerJun 08Sale124.0140,0004,960,3645,411,946Jun 09 04:14 PM
Klinger Shannon ThymeChief Legal OfficerJun 08Sale124.0956570,1116,516Jun 09 04:09 PM
Bancel StephaneChief Executive OfficerJun 07Option Exercise0.9940,00039,6005,451,946Jun 09 04:14 PM
Bancel StephaneChief Executive OfficerJun 07Sale125.8140,0005,032,4205,411,946Jun 09 04:14 PM
AFEYAN NOUBARDirectorJun 07Sale125.9115,0001,888,6012,157,209Jun 09 07:00 PM
Garay ArpaChief Commercial OfficerJun 06Sale125.752,290287,9722,547Jun 07 04:05 PM
Hoge StephenPresidentJun 02Sale130.3230940,2701,632,303Jun 05 04:16 PM
Klinger Shannon ThymeChief Legal OfficerJun 02Sale130.3211014,3365,942Jun 05 04:20 PM
Bancel StephaneChief Executive OfficerJun 01Option Exercise0.9940,00039,6005,451,946Jun 02 04:46 PM
Bancel StephaneChief Executive OfficerJun 01Sale127.9640,0005,118,4735,411,946Jun 02 04:46 PM
Bancel StephaneChief Executive OfficerMay 31Option Exercise0.9940,00039,6005,451,946Jun 02 04:46 PM
Bancel StephaneChief Executive OfficerMay 31Sale126.9140,0005,076,5585,411,946Jun 02 04:46 PM
AFEYAN NOUBARDirectorMay 31Sale127.3515,0001,910,3222,172,209Jun 02 07:00 PM
Hoge StephenPresidentMay 30Sale124.951,181147,5691,631,961May 31 04:21 PM
Bancel StephaneChief Executive OfficerMay 25Option Exercise0.9940,00039,6005,451,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 25Sale127.3640,0005,094,4215,411,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 24Option Exercise0.9940,00039,6005,451,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 24Sale131.4340,0005,257,2125,411,946May 26 04:59 PM
Bancel StephaneChief Executive OfficerMay 18Option Exercise0.9940,00039,6005,451,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 18Sale123.7740,0004,950,9995,411,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 17Option Exercise0.9940,00039,6005,451,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 17Sale125.3240,0005,012,6485,411,946May 19 04:12 PM
Bancel StephaneChief Executive OfficerMay 11Option Exercise0.9940,00039,6005,451,946May 12 04:08 PM
Bancel StephaneChief Executive OfficerMay 11Sale127.2640,0005,090,4865,411,946May 12 04:08 PM
Bancel StephaneChief Executive OfficerMay 10Option Exercise0.9940,00039,6005,451,946May 12 04:08 PM
Bancel StephaneChief Executive OfficerMay 10Sale131.6040,0005,264,0325,411,946May 12 04:08 PM
Hoge StephenPresidentMay 10Sale133.3725033,3441,630,732May 11 04:09 PM
Bancel StephaneChief Executive OfficerMay 04Option Exercise0.9940,00039,6005,451,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerMay 04Sale135.7040,0005,428,1255,411,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerMay 03Option Exercise0.9940,00039,6005,451,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerMay 03Sale131.2940,0005,251,4985,411,946May 05 04:08 PM
Bancel StephaneChief Executive OfficerApr 27Option Exercise0.9940,00039,6005,451,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 27Sale130.6140,0005,224,5705,411,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 26Option Exercise0.9940,00039,6005,451,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 26Sale131.7340,0005,269,1405,411,946Apr 28 04:51 PM
Bancel StephaneChief Executive OfficerApr 20Option Exercise0.9940,00039,6005,451,946Apr 21 05:05 PM
Bancel StephaneChief Executive OfficerApr 20Sale142.9940,0005,719,5405,411,946Apr 21 05:05 PM
Bancel StephaneChief Executive OfficerApr 19Option Exercise0.9940,00039,6005,451,946Apr 21 05:05 PM
Bancel StephaneChief Executive OfficerApr 19Sale142.8840,0005,715,2625,411,946Apr 21 05:05 PM
Bancel StephaneChief Executive OfficerApr 13Option Exercise0.9940,00039,6005,451,946Apr 14 04:02 PM
Bancel StephaneChief Executive OfficerApr 13Sale160.7640,0006,430,3405,411,946Apr 14 04:02 PM
Bancel StephaneChief Executive OfficerApr 12Option Exercise0.9940,00039,6005,451,946Apr 14 04:02 PM
Bancel StephaneChief Executive OfficerApr 12Sale156.6840,0006,267,3355,411,946Apr 14 04:02 PM
Bancel StephaneChief Executive OfficerApr 06Option Exercise0.9940,00039,6005,451,946Apr 07 05:31 PM
Bancel StephaneChief Executive OfficerApr 06Sale157.4740,0006,298,9505,411,946Apr 07 05:31 PM
Bancel StephaneChief Executive OfficerApr 05Option Exercise0.9940,00039,6005,451,946Apr 07 05:31 PM
Bancel StephaneChief Executive OfficerApr 05Sale154.6440,0006,185,5855,411,946Apr 07 05:31 PM
Bancel StephaneChief Executive OfficerMar 30Option Exercise0.9940,00039,6005,451,946Mar 31 04:10 PM
Bancel StephaneChief Executive OfficerMar 30Sale148.6340,0005,945,0545,411,946Mar 31 04:10 PM
Bancel StephaneChief Executive OfficerMar 29Option Exercise0.9940,00039,6005,451,946Mar 31 04:10 PM
Bancel StephaneChief Executive OfficerMar 29Sale148.3540,0005,934,0765,411,946Mar 31 04:10 PM
Bancel StephaneChief Executive OfficerMar 23Option Exercise0.9940,00039,6005,451,946Mar 24 04:11 PM
Bancel StephaneChief Executive OfficerMar 23Sale149.1940,0005,967,6835,411,946Mar 24 04:11 PM
Bancel StephaneChief Executive OfficerMar 22Option Exercise0.9940,00039,6005,451,946Mar 24 04:11 PM
Bancel StephaneChief Executive OfficerMar 22Sale150.2540,0006,009,8045,411,946Mar 24 04:11 PM
Bancel StephaneChief Executive OfficerMar 16Option Exercise0.9940,00039,6005,451,946Mar 17 04:07 PM
Bancel StephaneChief Executive OfficerMar 16Sale150.8740,0006,034,7245,411,946Mar 17 04:07 PM
Bancel StephaneChief Executive OfficerMar 15Option Exercise0.9940,00039,6005,451,946Mar 17 04:07 PM
Bancel StephaneChief Executive OfficerMar 15Sale148.8140,0005,952,4995,411,946Mar 17 04:07 PM
Bancel StephaneChief Executive OfficerMar 09Option Exercise0.9940,00039,6005,451,946Mar 10 04:15 PM
Bancel StephaneChief Executive OfficerMar 09Sale139.2040,0005,567,8595,411,946Mar 10 04:15 PM
Bancel StephaneChief Executive OfficerMar 08Option Exercise0.9940,00039,6005,451,946Mar 10 04:15 PM
Bancel StephaneChief Executive OfficerMar 08Sale141.3840,0005,655,3105,411,946Mar 10 04:15 PM
Klinger Shannon ThymeChief Legal OfficerMar 08Sale141.5156179,3885,820Mar 09 04:13 PM
Klinger Shannon ThymeChief Legal OfficerMar 07Option Exercise0.001,13806,381Mar 09 04:13 PM
Bancel StephaneChief Executive OfficerMar 02Option Exercise0.9940,00039,6005,451,946Mar 03 04:14 PM